isis 721744
Nucleic acidexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 22, 2020 (NCT04549922)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Kallikrein 1INHIBITOR
KLK1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04549922 | Phase 2 | Oct 22, 2020 | Hospital do Coracao, Hospital Moinhos de Vento, Ionis Pharmaceuticals, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hospital do Coracao | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Hospital Moinhos de Vento | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Ionis Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1